🇺🇸Stock Golden Finger📈📈

Just created a new WhatsApp group! Welcome everyone with a US stock account to join! 🔥Join now and get 5+ trading signals every day – perfect for beginners too! 🔥Add our WhatsApp:wa.me/12136758025 Get 3 days of top stock picks for FREE – claimed returns 10% to 300%!

Join my exclusive WhatsApp group for real-time stock trading action! I'll post every single trade I execute, complete with precise entry and exit levels. Stock trading fans, this is your invite! 👇 👇 wa.me/12136758025 Hurry, spots are limited—first in, first served!

$CANG Completed $10.5M equity investment; secured $65M more for AI expansion. Stock +2%–4% on fresh funding & AI infrastructure push. Advantages: Asset-light Bitcoin mining, strong AI pivot potential. Focus: AI compute growth post-BTC sales.

$FEED Investor acquires ~22% stake (Schedule 13D filed). Stock +9.96% on major ownership disclosure. Advantages: FDA-cleared ENvue navigation for safer enteral feeding. Focus: Precise tube placement, reduced complications.

$FSLY Q4 2025 Results: Record revenue $172.6M (+23% YoY), beat expectations. Guidance: FY2026 revenue $700-720M, adjusted EPS $0.23-0.29. Stock Surge: +~38.45% today on earnings beat & AI/security tailwinds. Advantages: Edge AI momentum, high-performance CDN, security ROI.

$LSCC low-power FPGAs; edge AI, 5G, automation; PQC/AI innovation, fabless model. Recent News: Q4 revenue $146M (+24%); EPS $0.32; Q1 guide $158-172M; conferences, PQC updates. Today's Rise: Stock +11.32% to $101.25; earnings beat, strong guidance, analyst upgrades.

$ELAB Surged 40.94%+ pre-market today. Driven by animal health licensing deal (myostatin/Activin-A) . Diversified: biotech, precision manufacturing, nuclear energy. Strong innovation in exosome & AI drug discovery. Low float, high volatility stock.

$ENTG up ~5.68% pre-market after strong Q4 2025 earnings. Revenue $823.9M beat estimates; adj. EPS $0.70 topped forecasts. Q1 2026 guidance also exceeded expectations. AI-driven demand boosts liquid filtration & CMP products.

$NKTR Surged ~18% today on strong REZOLVE-AD Phase 2b 36-week maintenance data. Rezpegaldesleukin showed durable & deepening responses (EASI-75 71-83%, EASI-100 up 2-5×). Monthly & quarterly dosing outperformed expectations. Supports Phase 3 advancement in atopic dermatitis.

$QS Eagle Line pilot launch; Q4 earnings Feb 11; board addition; VW partnerships; YTD -23%. Solid-state batteries; high density/safety; light-capex; EV market potential. Today's Rise: Pre-earnings buzz; Eagle Line hype; EV sector lift; 9.8% upside.

$WW GLP-1 platform expansion; investor conferences; short interest +21%; 14% rise on Amazon Wegovy; MS target $34.50. Weight mgmt leader; integrated GLP-1/tech; strong profits; B2B expansion. Wegovy news reaction; short squeeze; positive sentiment; 130% upside potential.

$CRCL USDC stablecoin leader ($73B); partnerships (Visa, Stripe); revenue shift to services; regulatory approvals. Polymarket USDC integration; analyst initiations/upgrades; Q4 earnings preview. Today's Rise: Up 7.2%; partnership boost; undervalued metrics; regulatory optimism.

$MAXN Solar tech leader; high-efficiency BC panels; strong IP (2K patents); durable designs. Aiko patent licensing ($236M); Malaysian sale; IP enforcement. Today's Rise: Up 20.64%; deal resolution; IP monetization; positive sentiment.

$AMSC Surged ~17.67% after strong Q3 FY2025 earnings. Revenue $74.5M (+21% YoY), adj. EPS $2.81 (beat estimates). Acquisitions (Comtrafo, NWL) strengthen grid & wind segments. Backlog >$250M; raised Q4 guidance (> $80M revenue).

$PAHC surged after Q2 FY2026 earnings beat expectations. EPS $0.87 vs expected $0.69; sales $373.9M vs $355.6M. Raised FY2026 EPS guidance to $2.93–$3.10. Driven by MFA portfolio growth, margin expansion (10.1% operating margin), and strong profit outlook.

$CISS It surged 38.16% pre-market, ranking among the top gainers of the day. SEC filings revealed that Imperial Petroleum Inc. holds an 81.9% stake in the company. This concentrated shareholding has fueled investor optimism.

$TLF Stock Surge: $TLF up 13.39% pre-market to $3.26. Key Reason: $0.75/share special dividend (26% yield). Volume: Surged above avg; attracts buyers at low price. Factors: 52-week range $2.56-$5.48; news boosts small-cap.

$BOXL Surge: +40% intraday (1.29-1.90 USD); volume 770K shares. FrontRow Symphony launch; Montgomery ISD partnership boosts confidence. Appeal: Historic low (52-wk 1.19); P/E -0.02 attracts value investors.

$DBVT Recent News: Phase 3 VITESSE success (46.6% response); €166.7M warrants; Artisan 7% stake. Company Strengths: Non-invasive Viaskin Peanut patch; FDA breakthrough; €306.9M cash for BLA. Today's Surge: MACD buy signal; trial momentum; volume spike (601K shares).